MedPath

浙江苏可安药业有限公司

Ownership
-
Established
2010-12-21
Employees
-
Market Cap
-
Website
http://sukean.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

78

NMPA:78

Drug Approvals

妇炎灵胶囊

Approval Number
国药准字Z33020435
Approval Date
Sep 23, 2024
NMPA

妇炎灵泡腾片

Approval Number
国药准字Z20030022
Approval Date
Sep 23, 2024
NMPA

灯盏花素片

Approval Number
国药准字Z20054220
Approval Date
Sep 20, 2024
NMPA

消咳喘片

Approval Number
国药准字Z20043327
Approval Date
Sep 20, 2024
NMPA

心脑健胶囊

Approval Number
国药准字Z33020443
Approval Date
Sep 20, 2024
NMPA

Rifampicin Capsules

Product Name
利福平胶囊
Approval Number
国药准字H33021456
Approval Date
Sep 20, 2024
NMPA

Ketotifen Fumarate Tablets

Product Name
富马酸酮替芬片
Approval Number
国药准字H33020917
Approval Date
Sep 14, 2024
NMPA

Benproperine Phosphate Capsules

Product Name
磷酸苯丙哌林胶囊
Approval Number
国药准字H33021488
Approval Date
Sep 14, 2024
NMPA

Lacidophilin Tablets

Product Name
乳酸菌素片
Approval Number
国药准字H20054535
Approval Date
Sep 10, 2024
NMPA

Naproxen Capsules

Product Name
萘普生胶囊
Approval Number
国药准字H33021011
Approval Date
Sep 10, 2024
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 8
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.